A Universal Mechanism Ties Genotype to Phenotype in Trinucleotide Diseases
暂无分享,去创建一个
[1] R. Albin,et al. Neurological abnormalities in a knock-in mouse model of Huntington's disease. , 2001, Human molecular genetics.
[2] L. Noble,et al. Microsatellites — Evolution and Applications , 1999, Heredity.
[3] O. Combarros,et al. GAA expansion size and age at onset of Friedreich’s ataxia , 2003, Neurology.
[4] O. Combarros,et al. Expanded GAA repeats and clinical variation in Friedreich's ataxia , 2004, Acta neurologica Scandinavica.
[5] James F. Gusella,et al. Molecular genetics: Unmasking polyglutamine triggers in neurodegenerative disease , 2000, Nature Reviews Neuroscience.
[6] H. Kawakami,et al. The effect of CAT trinucleotide interruptions on the age at onset of spinocerebellar ataxia type 1 (SCA1) , 1999, Journal of medical genetics.
[7] F. Squitieri,et al. CAG mutation effect on rate of progression in Huntington's disease , 2002, Neurological Sciences.
[8] H. Zoghbi,et al. Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I , 1993, Nature Genetics.
[9] P. Shelbourne,et al. Dramatic mutation instability in HD mouse striatum: does polyglutamine load contribute to cell-specific vulnerability in Huntington's disease? , 2000, Human molecular genetics.
[10] B Brinkmann,et al. Mutation rate in human microsatellites: influence of the structure and length of the tandem repeat. , 1998, American journal of human genetics.
[11] Y. Agid,et al. Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). , 1998, Human molecular genetics.
[12] D. Rubinsztein. Lessons from animal models of Huntington's disease. , 2002, Trends in genetics : TIG.
[13] Osamu Onodera,et al. SCA17 homozygote showing Huntington's disease‐like phenotype , 2004, Annals of neurology.
[14] F. Squitieri,et al. New Huntington disease mutation arising from a paternal CAG34 allele showing somatic length variation in serially passaged lymphoblasts , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[15] N W Wood,et al. Trinucleotide repeats and neurodegenerative disease. , 2004, Brain : a journal of neurology.
[16] Osamu Onodera,et al. Trinucleotide repeat length and rate of progression of Huntington's disease , 1994, Annals of neurology.
[17] Joonil Jung,et al. CREB-Binding Protein Modulates Repeat Instability in a Drosophila Model for PolyQ Disease , 2007, Science.
[18] J. Walcott,et al. Expression of expanded repeat androgen receptor produces neurologic disease in transgenic mice. , 2001, Human molecular genetics.
[19] F. Squitieri,et al. Highly disabling cerebellar presentation in Huntington disease , 2003, European journal of neurology.
[20] J. Brandt,et al. The association of CAG repeat length with clinical progression in Huntington disease , 2006, Neurology.
[21] A. Ciarmiello,et al. The search for cerebral biomarkers of Huntington's disease: a review of genetic models of age at onset prediction , 2006, European journal of neurology.
[22] D. Rubinsztein,et al. A molecular investigation of true dominance in Huntington’s disease , 1999, Journal of medical genetics.
[23] S. A. Ross,et al. A linear lattice model for polyglutamine in CAG-expansion diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[24] G. Bates. History of genetic disease: The molecular genetics of Huntington disease — a history , 2005, Nature Reviews Genetics.
[25] S. Choudhry,et al. CAG repeat instability at SCA2 locus: anchoring CAA interruptions and linked single nucleotide polymorphisms. , 2001, Human molecular genetics.
[26] Huda Y. Zoghbi,et al. Diseases of Unstable Repeat Expansion: Mechanisms and Common Principles , 2005, Nature Reviews Genetics.
[27] L. Ranum,et al. Pathogenic RNA repeats: an expanding role in genetic disease. , 2004, Trends in genetics : TIG.
[28] L. Pianese,et al. Determinants of onset age in Friedreich’s ataxia , 1998, Journal of Neurology.
[29] Shin Kwak,et al. FRIEDREICH'S ATAXIA , 1917, Nihon rinsho. Japanese journal of clinical medicine.
[30] Elizabeth Evans,et al. Dramatic tissue-specific mutation length increases are an early molecular event in Huntington disease pathogenesis. , 2003, Human molecular genetics.
[31] C. E. Pearson,et al. Repeat instability: mechanisms of dynamic mutations , 2005, Nature Reviews Genetics.
[32] M. Siciliano,et al. Dramatic, expansion-biased, age-dependent, tissue-specific somatic mosaicism in a transgenic mouse model of triplet repeat instability. , 2000, Human molecular genetics.
[33] C J Lumsden,et al. Inherited neurodegenerative diseases: the one-hit model of neurodegeneration. , 2001, Human molecular genetics.
[34] M. Hayden,et al. The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. , 1997, American journal of human genetics.
[35] Thorsten Schmidt,et al. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis , 2004, The Lancet Neurology.
[36] F. Giubilei,et al. Natural history of cardiac involvement in myotonic dystrophy: Correlation with CTG repeats , 2000, Neurology.
[37] A. Messer,et al. Msh2 deficiency prevents in vivo somatic instability of the CAG repeat in Huntington disease transgenic mice , 1999, Nature Genetics.
[38] K. Fischbeck,et al. Androgen receptor mutation in Kennedy's disease. , 1999, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[39] M. F. Perutz,et al. Cause of neural death in neurodegenerative diseases attributable to expansion of glutamine repeats , 2001, Nature.
[40] M. Hayden,et al. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course. , 2003, Brain : a journal of neurology.